RIDASCREEN^® HSV 1+2 IgG

Product Code K5021

Intended use:

For in vitro diagnostic use. The RIDASCREEN^® HSV 1+2 IgG test is an enzyme immunoassay (EIA) for the semi-quantitative determination of IgG antibodies against Types 1 and 2 of the Herpes simplex virus (HSV 1 and HSV 2) in human serum. The test is based on total antigen and reacts with antibodies against both types in parallel. It should be used for screening for IgG antibodies against HSV.

General information:

After infection with HSV, specific antibodies are formed against the pathogen as a result of the response from the immune system. By using immunological methods, it is possible to determine the antibodies in the serum. The test method used and the choice of the pathogen-specific antigen both have a significant bearing on the meaningfulness of the test.

Because it is possible to differentiate between the individual immunoglobulin classes in the enzyme immunoassay, more precise statements about the immunological status of a patient can be made than those which are based on other serological methods (such as the haemagglutination inhibition test or the complement fixation test).

Test principle
Purified antigens are coated to a microwell plate. Antibodies in the patient samples bind to the antigens and are determined during the second incubation step by using enzyme-labelled anti-human antibodies (the conjugate). The enzyme converts the colourless substrate (H₂O₂/TMB) to a blue end product. The enzyme reaction is stopped by adding sulphuric acid and the colour of the mixture switches from blue to yellow at the same time. The final measurement is carried out at 450 nm on a photometer using a reference wavelength ≥ 620 nm.

Specifications: